A phase II study evaluating a decision aid for women considering neoadjuvant systemic therapy for operable invasive breast cancer (ANZ 1301 DOMINO)

Full description

* 51 eligible women * Offered a custom-designed DA focussed on the decision about neoadjuvant systemic therapy. * An assessment will be made of its utility and acceptability for patients and investigators using measures: • Decision Aid Feedback • Decision Conflict Scale • STAI-6 • DMPQ • Information and Involvement Preferences • Knowledge of Decision Aid Information • Satisfaction With Decision Scale • Preferred and Achieved Decision Control (first and second part of the DMPQ) • FOP 12 • Distress Thermometer • EQ-5D-5L (optional). The content of the DA is based on the DOMINO survey results (ANZ 1301 DOMINO Project 1: Exploring decision making about neoadjuvant chemotherapy for women with operable breast cancer; ACTRN12613000658718), including information delivery preferences and factors considered by patients to be relevant to their decision.

Notes

HeSANDA 1.0.0